Gene · 4881
Papers1,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complete loss of the atrial natriuretic peptide-converting enzyme Corin and CHAF-LA syndrome: Implications to natriuretic peptide physiology and left atrium health. | Clin Transl Med | 2024 | 38224201 | PubTator, text mining | PubMed |
| ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1. | J Transl Med | 2024 | 38212795 | PubTator, text mining | PubMed |
| Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis. | Int J Cancer | 2024 | 38151776 | PubTator, text mining | PubMed |
| Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective. | J Cell Mol Med | 2024 | 37847125 | PubTator, text mining | PubMed |
| A Review of Rattlesnake Venoms. | Toxins (Basel) | 2023 | 38276526 | PubTator, text mining | PubMed |
| New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer. | Life (Basel) | 2023 | 38255667 | PubTator, text mining | PubMed |
| Big peptide drugs in a small molecule world. | Front Chem | 2023 | 38144886 | PubTator, text mining | PubMed |
| n-Tuples on Scaffold Diversity Inspired by Drug Hybridisation to Enhance Drugability: Application to Cytarabine. | Mar Drugs | 2023 | 38132958 | PubTator, text mining | PubMed |
| Analysis of Rare Variants in 470,000 Exome-Sequenced UK Biobank Participants Implicates Novel Genes Affecting Risk of Hypertension. | Pulse (Basel) | 2023 | 38090255 | PubTator, text mining | PubMed |
| Transcriptome and Metabolome Analyses Reveal That Jasmonic Acids May Facilitate the Infection of Cucumber Green Mottle Mosaic Virus in Bottle Gourd. | Int J Mol Sci | 2023 | 38068889 | PubTator, text mining | PubMed |
| Exploring extracellular matrix and prostaglandin pathway alterations across varying resection margin distances of right-sided colonic adenocarcinoma. | BMC Cancer | 2023 | 38062443 | PubTator, text mining | PubMed |
| Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis. | Front Oncol | 2023 | 38045004 | PubTator, text mining | PubMed |
| Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failure. | Expert Opin Investig Drugs | 2023 | 38032188 | PubTator, text mining | PubMed |
| Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy. | Front Pharmacol | 2023 | 38026943 | PubTator, text mining | PubMed |
| The discovery of hidden guanylate cyclases (GCs) in the Homo sapiens proteome. | Comput Struct Biotechnol J | 2023 | 38022692 | PubTator, text mining | PubMed |
| Molecular Footprints on Osmoregulation-Related Genes Associated with Freshwater Colonization by Cetaceans and Sirenians. | J Mol Evol | 2023 | 38010516 | PubTator, text mining | PubMed |
| COVID-19 and Kidney: The Importance of Follow-Up and Long-Term Screening. | Life (Basel) | 2023 | 38004277 | PubTator, text mining | PubMed |
| XBP1 Modulates the Aging Cardiorenal System by Regulating Oxidative Stress. | Antioxidants (Basel) | 2023 | 38001786 | PubTator, text mining | PubMed |
| Unveiling the potential role of natriuretic peptide receptor a isoforms in fine-tuning the cGMP production and tissue-specific function. | Sci Rep | 2023 | 37993528 | PubTator, text mining | PubMed |
| Comparative Transcriptome Analysis between Resistant and Susceptible Pakchoi Cultivars in Response to Downy Mildew. | Int J Mol Sci | 2023 | 37958694 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4881/papers?page=6